levofloxacin has been researched along with Infections, Coronavirus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, MB; Neal, JM; Vlassakov, K | 1 |
| Beare, PA; Bloom, ME; Broeckel, RM; Flather, DP; Kendall, BL; Morris, CN; Offerdahl, DK; Scroggs, SLP | 1 |
2 other study(ies) available for levofloxacin and Infections, Coronavirus
| Article | Year |
|---|---|
Neuraxial anaesthesia in the context of bacterial meningitis and COVID-19.
Topics: Anesthesia, Spinal; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Coronavirus Infections; COVID-19; Humans; Levofloxacin; Male; Meningitis, Bacterial; Middle Aged; Pandemics; Pneumonia, Viral; Risk Factors | 2020 |
Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV.
Topics: A549 Cells; Angiotensin-Converting Enzyme 2; Animals; Anti-Bacterial Agents; Antiviral Agents; Cell Line; Chlorocebus aethiops; Ciprofloxacin; Coronavirus Infections; COVID-19 Drug Treatment; Enoxacin; Fluoroquinolones; Humans; Levofloxacin; Middle East Respiratory Syndrome Coronavirus; Moxifloxacin; SARS-CoV-2; Vero Cells | 2020 |